105 related articles for article (PubMed ID: 20605708)
1. Contemporary post surgical management of differentiated thyroid carcinoma.
Tala H; Tuttle RM
Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):419-29. PubMed ID: 20605708
[TBL] [Abstract][Full Text] [Related]
2. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
3. Recombinant thyroid-stimulating hormone in differentiated thyroid cancer.
Krausz Y; Uziely B; Nesher R; Chisin R; Glaser B
Isr Med Assoc J; 2001 Nov; 3(11):843-9. PubMed ID: 11729583
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of differentiated thyroid carcinoma.
Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
Lind P; Igerc I; Kohlfürst S
Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
[TBL] [Abstract][Full Text] [Related]
6. [Differentiated thyroid carcinoma--how to improve the long-term results? Twenty-five-year outcomes of 850 patients].
Melliere D; Hindie E; Becquemin JP; Desgranges P; Allaire E; Geachan E
Bull Acad Natl Med; 2006 Jan; 190(1):89-106; discussion 106-9. PubMed ID: 16878448
[TBL] [Abstract][Full Text] [Related]
7. Postoperative management of thyroid carcinoma.
Manzone TA; Dam HQ; Intenzo CM; Sagar VV; Schneider CJ; Seshadri P
Surg Oncol Clin N Am; 2008 Jan; 17(1):197-218, x. PubMed ID: 18177807
[TBL] [Abstract][Full Text] [Related]
8. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
Shaha AR
Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
[TBL] [Abstract][Full Text] [Related]
9. Follow up approaches in thyroid cancer: a risk adapted paradigm.
Tuttle RM; Leboeuf R
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):419-35, ix-x. PubMed ID: 18502335
[TBL] [Abstract][Full Text] [Related]
10. [Radical surgical treatment of differentiated thyroid cancer--necessity or over-enthusiasm?].
Nowak W; Szybiński P
Wiad Lek; 2001; 54 Suppl 1():189-97. PubMed ID: 12182024
[TBL] [Abstract][Full Text] [Related]
11. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
[TBL] [Abstract][Full Text] [Related]
12. Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging.
Lin JD; Chao TC; Chen ST; Huang YY; Liou MJ; Hsueh C
Surg Oncol; 2007 Aug; 16(2):107-13. PubMed ID: 17600699
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
Vassilopoulou-Sellin R; Schultz PN; Haynie TP
Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
[TBL] [Abstract][Full Text] [Related]
14. Childhood and adolescent thyroid carcinoma.
Grigsby PW; Gal-or A; Michalski JM; Doherty GM
Cancer; 2002 Aug; 95(4):724-9. PubMed ID: 12209714
[TBL] [Abstract][Full Text] [Related]
15. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
16. Thyroid cancer outcomes in Filipino patients.
Kus LH; Shah M; Eski S; Walfish PG; Freeman JL
Arch Otolaryngol Head Neck Surg; 2010 Feb; 136(2):138-42. PubMed ID: 20157058
[TBL] [Abstract][Full Text] [Related]
17. [Survival potentials of patients with papillary carcinoma of the thyroid gland in Hungary].
Esik O; Tusnády G; Daubner K; Németh G; Füzy M; Szentirmay Z
Orv Hetil; 1996 May; 137(20):1067-78. PubMed ID: 8657418
[TBL] [Abstract][Full Text] [Related]
18. Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation.
Grewal RK; Larson SM; Pentlow CE; Pentlow KS; Gonen M; Qualey R; Natbony L; Tuttle RM
J Nucl Med; 2009 Oct; 50(10):1605-10. PubMed ID: 19759114
[TBL] [Abstract][Full Text] [Related]
19. Follicular thyroid cancer.
Grebe SK; Hay ID
Endocrinol Metab Clin North Am; 1995 Dec; 24(4):761-801. PubMed ID: 8608779
[TBL] [Abstract][Full Text] [Related]
20. Cost-effective management of low-risk papillary thyroid carcinoma.
Shrime MG; Goldstein DP; Seaberg RM; Sawka AM; Rotstein L; Freeman JL; Gullane PJ
Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1245-53. PubMed ID: 18086967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
